Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022

Company Announcement

  • Net sales of DARZALEX® in 2022 totaled USD 7,977 million
  • Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen)

COPENHAGE… Read full article


Posted

in

by

Tags:

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *